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Abstract
The membrane cytoskeleton linker ezrin participates in several functions downstream of the receptor Met in response to
Hepatocyte Growth Factor (HGF) stimulation. Here we report a novel interaction of ezrin with a HECT E3 ubiquitin ligase,
WWP1/Aip5/Tiul1, a potential oncogene that undergoes genomic amplification and overexpression in human breast and
prostate cancers. We show that ezrin binds to the WW domains of WWP1 via the consensus motif PPVY
477 present in ezrin’s
C-terminus. This association results in the ubiquitylation of ezrin, a process that requires an intact PPVY
477 motif.
Interestingly ezrin ubiquitylation does not target the protein for degradation by the proteasome. We find that ezrin
ubiquitylation by WWP1 in epithelial cells leads to the upregulation of Met level in absence of HGF stimulation and increases
the response of Met to HGF stimulation as measured by the ability of the cells to heal a wound. Interestingly this effect
requires ubiquitylated ezrin since it can be rescued, after depletion of endogenous ezrin, by wild type ezrin but not by a
mutant of ezrin that cannot be ubiquitylated. Taken together our data reveal a new role for ezrin in Met receptor stability
and activity through its association with the E3 ubiquitin ligase WWP1. Given the role of Met in cell proliferation and
tumorigenesis, our results may provide a mechanistic basis for understanding the role of ezrin in tumor progression.
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Introduction
The activation of the Met receptor by its ligand, the Hepatocyte
Growth Factor (HGF), elicits complex biological responses in
epithelial cells. HGF induces proliferative and anti-apoptotic
signals. It also triggers cell scattering and motility and promotes
morphogenic programs when cells are cultured in three-dimen-
sional matrix [1].
It has been shown that the membrane-cytoskeleton linker, ezrin,
participates in several events induced by Met activation. Ezrin
belongs to the ERM (Ezrin, Radixin, Moesin) protein family. The
activity of these proteins is negatively regulated by an intramo-
lecular interaction between their N-terminal and C-terminal
domains that masks their membrane and actin cytoskeleton
binding sites [2]. Activation of the proteins requires conforma-
tional changes triggered by their sequential binding to PIP2
followed by phosphorylation of a conserved threonine residue in
their COOH-terminus [3]. Following HGF stimulation of
epithelial cells, ezrin is phosphorylated at specific tyrosine residues
involved in various signalling pathways [4,5]. We have shown, in a
tubulogenesis assay, that phosphorylation of ezrin at tyrosine 353
signals cell survival through the PI3-K pathway [5] whereas its
phosphorylation at tyrosine 145 controls cell proliferation [6]. The
association of ERM (Ezrin, Radixin, Moesin) proteins with
CD44v6, a coreceptor of Met, is necessary for HGF-mediated
activation of Ras by the guanine nucleotide exchange factor Sos
[7]. Moreover, ezrin is involved in several HGF-induced functions
that require actin cytoskeleton remodeling such as cell morpho-
genesis and motility [4,7–9]. In particular, ezrin phosphorylation
at tyrosine 477 is required for HGF-induced cell scattering
through the recruitment and activation of the Fes kinase [9].
The remodeling of the actin cytoskeleton and adhesion
complexes triggered by HGF are mediated by non receptor
tyrosine kinases from the Src family [4,6,9]. Because ezrin is a
substrate of Src family kinases [6,10] we performed a modified
two-hybrid screen to identify the proteins interacting with ezrin
phosphorylated by Src family kinase. We identified an interaction
of ezrin with WWP1/AIP5/Tiul1 a type E3 ubiquitin ligase that
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protein C terminus) [11].
Through ubiquitylation of different targets, WWP1 has been
implicated in the regulation of cell growth and apoptosis. WWP1
was found to target transcription factors including p53 [12], the
Kru ¨ppel-like factors KLF2 [13], KLF5 [14], p63 [15] and Runx2
[16]. WWP1 has also a regulatory role in receptor signalling. A
negative regulation of TGF-b signalling by WWP1 has been
reported [17,18]. Through its interaction with Smad7, WWP1
causes ubiquitylation and degradation of the TGF-b receptor type
1 [18]. WWP1 can also interact with TGIF to induce the
degradation of Smad 2 [17]. Recently, it was shown that WWP1
upregulates the activity of ErbB2 and EGF receptors [19]. This
occurs through the interaction of WWP1 with ring finger protein
11 (RNF11), a negative regulator of these receptors.
Here we report a novel mechanism by which ezrin regulates the
level and the activity of Met through its interaction with WWP1.
We found that the interaction between WWP1 and ezrin is
mediated by the WW domains of WWP1 and the PPVY
477 motif
present in ezrin. We observed that ezrin is ubiquitylated by WWP1
however this ubiquitylation does not target ezrin for degradation.
Rather, the interaction of ezrin with WWP1 increases the levels of
Met in absence of HGF stimulation. This effect requires ezrin
since depletion of ezrin in cell lines stably expressing WWP1
abolishes the stabilization of Met. Moreover, we show that cells
expressing WWP1 display an increase in wound healing response
when stimulated with HGF and that this response requires
ubiquitylated ezrin. Altogether our data suggest that Met stability
is regulated via a pathway that requires the joint active function of
ezrin and WWP1.
Materials and Methods
Reagents and Antibodies
The following antibodies were used: affinity-purified rabbit
polyclonal anti-vesicular stomatitis virus glycoprotein epito-
pe (VSVG) and anti-ezrin antibodies [20]; mouse monoclonal
anti-Myc (clone 9E10); mouse monoclonal anti- tubulin, Sigma-
Aldrich; Rat monoclonal anti E-cadherin (Zymed); mouse
monoclonal anti-Flag M2 (Sigma-Aldrich); mouse monoclonal
anti-Met (clone 25F2; Cell Signaling); polyclonal anti-WWP1
antibody was generated against a peptide of WWP1 aa 163–176
C-NGDALHENGEPSAR. Peptide and rabbit immunization were
performed by Covalab. Affinity immunopurification was per-
formed against His-WWP1 (aa 1–413). Horseradish peroxidase–
conjugated goat anti-rabbit, anti-mouse, anti-rat secondary
antibodies, Cy3- and Alexa 488–conjugated goat anti-rabbit,
anti-mouse, anti-Rat 546 secondary antibodies were from Jackson
ImmunoResearch Laboratories. Rhodamine-phalloidin and Alexa
Fluor 350 phalloidin were from Molecular Probes.
Plasmids and cDNA Constructs
Ezrin plasmids for eukaryotic expression and GST-tagged
plasmids were described previously [21,22]. Point mutations were
generated using the QuickChange mutagenesis kit (Stratagene, La
Jolla, CA). Flag-tagged WWP1 and WWP1 C890A in CMV 7.1
plasmid were described previously [17]. GFP-WWP1 was gener-
ated by PCR of WWP1 and inserted into pEGFP C2. His-tagged
WWP1 (aa 1–413) was generated by PCR and inserted into the
FseI and AscI sites of pET28 (pET plasmids were a gift from Dr.
A. Gautreau.). PC tagged WWP1 was cloned in pCDNA5/FRT/
V5-His modified as described previously [23]. GST-fusions of
various WWP1 domains were performed as follows: GST-WWP1
full length was cloned into pGEX 4T-1 into EcoRI 59 and NotI 39;
GST-WW domain 1 (aa 350–381), WW domain 2 (aa 382–412),
WW domain 3 (aa 456–488), WW domain 4 (aa 496–528), were
cloned by PCR of the listed region into pGEX 4T-1 using EcoRI
59 and Not1 39. The plasmids pcDNA3 encoding VSVG-tagged
wild type ubiquitin, ubiquitin KO mutated on all lysines or
mutated on all but one of the lysine residues involved in the
polymerization of ubiquitin molecules were a kind gift from Dr.
Christel Brou [24].
RNA Interference
For depletion of WWP1, 293T cells were transfected with the
ON-target plus SMART pool from Thermo Scientific Dharmacon
(UK) at the concentration of 10 nM, using RNAiMAX (Invitro-
gen). Cells were analyzed at different times after transfection and
complete depletion was achieved 4 days after transfection.
Cell Culture and Transfection
293T cells and LLC-PK1 cells (CCL 101 American Type
Culture Collection, Molsheim) were grown in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine
serum and maintained in 10% CO2 at 37uC. 293T cells were
transiently transfected by the calcium phosphate method and
analyzed 24 or 48 h after transfection. Pools of LLC-PK1 cells
stably expressing GFP or GFP-WWP1 were obtained by selection
with G418 (0.7 g/l) after cell transfection by electroporation with
the corresponding plasmids. The stable Flp-In 293 cell lines
expressing WWP1 were obtained according to the manufacturer’s
protocols (Invitrogen) and grown in presence of 200 mg/ml
Hygromycin. The stable Flp-In
TM T-REx
TM 293 (Invitrogen) cell
line expressing PC tagged WWP1 was obtained as described
previously [23] and grown in presence of 200 mg/ml Hygromycin.
Immunoprecipitation and GST Pull-down Experiments
Cells transfected with the appropriate plasmid(s), were washed
with cold PBS followed by lysis in RIPA buffer (50 mM Hepes
pH 7.5, 10 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.1%
SDS;0.5%deoxycholate)1 mMorthovanadatewhenindicated,plus
protease inhibitors cocktail (Sigma). The cell lysates were spun at
20.0006gfor20 min;theclearedlysateswereincubatedfortwohours
at4uCwiththeindicatedantibodyforimmunoprecipitationtogether
with 10 ml protein-G beads (Perbio), or with various GST-tagged
proteinsboundtoglutathioneSepharose4B(GEHealthcare)forpull-
down experiments. Beads were then washed 46500 ml with RIPA
buffer. For ubiquitylation analysis, samples were ran on 3–8%
gradient NuPAGETris-Acetate gels(Invitrogen).
Membrane Cytosol Fractionation
Cytosol/membrane fractionation was performed as described
previously [3]. In brief, cells were mechanically disrupted using a
cell cracker in PBS containing a cocktail of protease inhibitors
(Sigma). The homogenates were clarified by centrifugation at
6006g. The resultant supernatant was spun at 100,0006g for
30 min to obtain the membrane fraction. Supernatant and
membrane pellets were analyzed by SDS-PAGE and immuno-
blotting.
In vitro and in vivo Ubiquitylatio
For in vitro ubiquitylation assay, 293T cells were transfected
with the plasmid encoding GFP-WWP1 and the protein was
purified using the GFP-Trap method according to manufacturer’s
recommendation (Chromotek; Planegg-Martinsried). GST-ezrin
was purified as described above and dialyzed against the
ubiquitylation buffer. The in vitro ubiquitylation reactions were
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buffer (25 mM Tris-HCl at pH 7.6, 5 mM MgCl2, 0.1 M NaCl,
1 mM DTT, 2 mM ATP supplemented with the protease
inhibitor cocktail, and the phosphatase inhibitor cocktail II from
Sigma) containing the following components: 100 ng of E1
(BostonBiochem, Cambridge, MA), 150 ng of UbcH5a (Boston-
Biochem), 5 mg of Myc-ubiquitin (BostonBiochem), ,1 mg GFP-
WWP1 coupled to beads and 1,5 mg purified GST-ezrin. The
reactions were terminated by adding the Laemmli buffer to the
beads.
For the in vivo ubiquitylation experiments in which denatured
extracts were used, cells expressing Flag-WWP1, ezrin-VSVG and
Myc-His-ubiquitin were lysed in RIPA buffer without EDTA, the
extracts were adjusted to 1% SDS and boiled for 2 min.
Denatured extracts were then put on ice for 10 min and diluted
with cold RIPA buffer without EDTA to adjust SDS concentration
to 0.5%. For non denaturing conditions, cells were lysed in RIPA
buffer without EDTA. The lysates were incubated with TALON
beads precharged with Co
2+ (Clontech, Saint-Germain en Laye,
France). After 1 h incubation, beads were washed and proteins
were solubilized in Laemmli buffer.
Pulse Chase Experiments
Metabolic labeling was performed with 250 mCi/ml
35S-labeled
Met and Cys from Redivue Promix (Amersham Biosciences). Flp-
In
TM T-REx
TM 293 cells stably expressing PC tagged WWP1 or
transfected with the empty plasmid were grown in 6 cm dish,
labeled for 15 min and chased for the indicated time in standard
DMEM containing 10% FBS. After immunoprecipitation and
SDS-PAGE, signals were quantified using a STORM 860
PhosphorImager and ImageQuant software (Amersham Biosci-
ences).
Immunofluorescence
Cells were fixed with PFA (4%) and processed for immunoflu-
orescence. Images were taken with a 90i upright Microscope
Nikon Microsystems equipped with PIFOC Objective stepper and
a 100X/1.4 N.A. Plan Apochromat objective. Slices were
acquired along the Z axis every 0.2 mm. Deconvolution was done
by the Metamorph module (Roper Scientific) using the Meinel
algorithm.
Met Stability and Activity
Met level was measured in LLC-PK1 cells stably expressing
GFP or GFP-WWP1 after 5 hours starvation in DMEM
supplemented with 1% FBS. For ezrin depletion, LLC-PK1 cells
expressing GFP-WWP1 were electroporated with plasmids coding
for scrambled shRNA or shRNA targeting porcine ezrin and for
the reporter m-cherry [9]. The Met levels were analyzed four days
after transfection as described above. Significance was tested using
a paired t-test (SigmaStat).
For the wound healing assay, LLC-PK1 cells expressing GFP or
GFP-WWP1 were plated onto ibiTreat dishes (IBIDI) and starved
for 5 hours in DMEM supplemented with 1% FBS. The cell
monolayer was wounded with a 10 ml tip, and when indicated
HGF (120 ng/ml) was added to the medium. Cells were imaged
for 16 hours at 37uC and 5% CO2 with an Eclipse Ti Inverted
Microscope (Nikon) equipped with a 20x/0.45 NA Plan Fluor
ELWD objective, a CoolsnapHQ2 camera (Roper) and The Cube
and The Box (Life Imaging Services). For each condition, single
cell speed was measured at 13 different positions along the wound
with Metamorph software. Only cells expressing the indicated
proteins and shRNA, detected through the expression of
fluorescent reporters, were analyzed.
Results
Identification of the E3 Ubiquitin Ligase, WWP1, as an
Ezrin Partner
We have performed a two-hybrid screen with yeast transformed
or not with the Lyn kinase to identify partners of ezrin
phosphorylated by Src family kinases [9]. We used full-length
ezrin and ezrin deleted of the last 52 amino acids as baits. Deleting
the last 52 amino acids disrupts the strong intramolecular
interaction between the N-terminal and C-terminal domains, an
interaction that is likely to mask binding sites to ezrin partners [2].
WWP1 was identified in the screen performed with yeast
transformed with the Lyn kinase and ezrin truncated for the last
52 amino acids but was neither found in the screen performed with
full length ezrin as bait nor in the screen performed in the absence
of the Lyn kinase. The region identified in the two-hybrid screen
encompasses the C2 domain and the first two WW domains (aa
48–405) of WWP1 (Fig. 1A).
Ezrin Interacts with WWP1 through its PPVY
477 Motif
To confirm the interaction between WWP1 and ezrin we
performed experiments to pull down Flag-WWP1 expressed in
293TcellswithvariousGST-ezrindomains.Weidentifiedaspecific
interactionwithGST-full length ezrinaswell aswithGSTN-ter (aa
1–308) and GST C-ter (aa 308–585) domains of ezrin (Fig. 1B),
indicatingthattherearetwobindingsitesforWWP1inezrin,onein
the C-terminus and the second inthe N-terminus.
WWP1 contains four WW domains that belong to the class I
family of WW domains, shown to bind to PPXY motifs [25]. The
C-terminal domain of ezrin contains a PPXY motif (PPVY
477), we
therefore determined if the interaction of ezrin and WWP1 occurs
through this. We generated GST-fusions of ezrin full length or C-
terminal domain alone mutated at a specific residue in this motif
(ezrin P474A, P475A or Y477F). Disrupting PPVY
477 in full-
length ezrin did not abolish the interaction of WWP1 with ezrin
(Fig. 1C). However, disrupting PPVY
477 in the C-terminal domain
alone of ezrin completely abolished the interaction with WWP1
(Fig. 1D). These results support our above data showing that there
is a binding site within the N-terminus of ezrin and show that the
second binding site requires the C-terminal PPVY
477 motif of
ezrin.
Separate WW domains from the same protein can have
different specificity for protein ligands [26]. To test whether the
WW domains of WWP1 have the same specificity towards ezrin,
and to determine whether the recognition in the N-terminal
domain of ezrin is mediated by a WW domain interaction, we
performed pull down experiments using GST tagged WW
domains 1 through 4 of WWP1 with various domains of VSVG-
ezrin expressed in 293T cells. WW domains 1 and 3 were found to
interact with full-length and with the C-ter domain of ezrin (Fig. 2).
No interaction of WW domain 2 with either forms of the protein
was found while WW domain 4 interacted only with the C-ter
domain of ezrin. No interaction was detected between the N-ter
domain of ezrin and any of the WW domains, indicating that the
interacting site of WWP1 within the N-ter domain of ezrin is not
WW domain dependent.
Ezrin and WWP1 Colocalize at the Membrane
To address in which cellular compartment the ezrin/WWP1
complex could form we performed membrane/cytosol fraction-
ation of 293T cell lysates. We developed an antibody to human
WWP1 against a peptide comprising amino acids 163–176 that
recognized one band only in human cell lines with the molecular
weight of WWP1 (Fig. 3A). A complete disappearance of the band
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treated with siRNA targeting WWP1 further confirming the
specificity of our antibody (Fig. 3B). As previously reported, ezrin
is present both in the cytoplasm and associated with the
membranes. However, because a small pool of ezrin (,10%) is
associated with the membrane [3], it can be detected in this
fraction only when it is concentrated. In contrast, WWP1 is mostly
present in the membrane fraction with detectable levels in the
cytoplasmic fraction (Fig. 3C). We then performed immunofluo-
rescence analysis to determine in which cellular compartment
WWP1 was present. It has been previously shown that WWP1
localizes to the nucleus and cytoplasm in MDCK and HeLa cells
[17,18]. By immunofluorescence the antibody we developed to
human WWP1 did not recognize the endogenous porcine protein.
We therefore generated pools of LLC-PK1 cell stably expressing
GFP-tagged forms of WWP1. LLC-PK1 cells are derived from
kidney proximal tubules and display characteristic features of
polarized absorptive cells. In these cells, WWP1 showed
colocalization with endogenous ezrin at the microvilli and with
E-cadherin at the cell-cell junctions (Fig. 3D).
Ezrin is Ubiquitylated by WWP1
Given the interaction between WWP1 and ezrin, we tested
whether WWP1 induced the ubiquitylation of ezrin. We expressed
WWP1 wild type or catalytically inactive (C883A) forms in 293T
cells in the presence of ubiquitin followed by immunoprecipitation
of endogenous ezrin. Expression of WWP1, but not WWP1
(C883A), led to a distinct pattern of high molecular weight bands
that correspond to multi2/poly-ubiquitylated ezrin (Fig. 4A). This
pattern of ubiquitylation was still observed when denaturing
conditions were used to purify ubiquitylated conjugates (Fig. 4B).
We next tested whether WWP1 promoted ezrin ubiquitylation in
vitro. We performed an ubiquitin conjugation assay using purified
GFP-WWP1 bound to beads and purified GST-ezrin in presence
of ubiquitylation reagents. No ezrin ubiquitylation could be
observed with the full length protein (unpublished data). One
possible reason for this negative result would be that the full length
ezrin is in a closed conformation therefore its interaction with
WWP1 might be hampered resulting in a reduced accessibility to
the ubiquitylation site. We therefore used an open ezrin form in
which the last 29 amino acids were deleted (ezrin D29). As shown
in figure 4C, a ladder of ubiquitylated ezrin was observed. We also
observed a ladder of ubiquitin intensifying above the molecular
weight band for WWP1 suggesting that WWP1 may self-
ubiquitylate. Under the same conditions, no ladder was observed
when WWP1 and ezrin D29 were incubated in absence of
ubiquitin or when WWP1 was replaced by GFP alone (Fig. 4C).
To identify the type of isopeptide linkage catalyzed by WWP1,
we coexpressed ezrin-Myc, WWP1 and VSVG-tagged ubiquitin
either wild type, mutated in all lysine residues used to polymerize
ubiquitin residues (UbKO) or in all but one lysine residue (Ub
KOK11, KOK29, KOK48, KOK63). The same pattern of
ubiquitylation was observed with the different forms of ubiquitin.
The expression level of ubiquitin wild type observed in total cell
lysates was lower (data not shown) resulting in lower intensity of
ezrin ubiquitylated bands. Moreover, Ub KOK63 is poorly
incorporated (Brou, C. personnal communication) therefore the
ezrin ubiquitylated bands could only be detected after longer
exposure (unpublished results) (Fig. 4D). Notably, cells expressing
ubiquitin KO, which can only form isopeptide bond between the
last glycine (G76) and lysine residues in ezrin, displayed the same
profile of ubiquitylation as cells expressing wild type ubiquitin.
Altogether these data provided compelling evidence that ezrin is
Figure 1. Ezrin interacts with the E3 ubiquitin ligase WWP1. (A)
Schematic representation of the structural organization of ezrin and
WWP1. (B) Lysates from 293T cells transfected with Flag-WWP1 were
incubated with immobilized GST or GST fused to full length, N-ter or C-
ter ezrin and the blot was performed with the anti-Flag antibody. Lower
panel: the blot was stained with ponceau S to reveal the GST-tagged
proteins. (C) An extract of 293T cells transfected with Flag-WWP1 was
incubated with immobilized GST or GST fused to ezrin wild type or
carrying mutations in the PPVY motif. Lower panel: Ponceau S staining
of the blot. (D) Extract of cells transfected with Flag-WWP1 was
incubated with immobilized GST or GST fused to the C-ter domain of
ezrin either wild type or carrying the mutation in the PPVY motif. Lower
panel: Coomassie staining of GST tagged proteins.
doi:10.1371/journal.pone.0037490.g001
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37490Figure 2. Mapping the interaction of ezrin with individual WW domain of WWP1. The lysates of 293T cells transfected with the indicated
VSV-G tagged ezrin constructs were incubated with immobilized GST or GST fused to WW domains 1 to 4. Immunoblotting was performed with the
anti-VSVG antibody. Lower panel: GST tagged proteins were revealed with ponceau S.
doi:10.1371/journal.pone.0037490.g002
Figure 3. Subcellular localization of ezrin and WWP1. (A) Immunoblot with the anti WWP1 antibody on extracts from 293T cells expressing
WWP1, 293T and HeLa cells. (B) Blot was performed with the anti-WWP1 antibody on lysates of 293T cells transfected with scramble siRNA (si scr) or a
pool of siRNA targeting WWP1 (si WWP1). Tubulin serves as loading control. (C) Membrane and cytosolic fractions of 293T cells were blotted with
ezrin and WWP1 antibodies. The receptor Met was used as a control for cell fractionation. (D) Immunofluorescence was performed on LLC-PK1 cells
stably expressing WWP1-GFP with an anti- E-cadherin (red) or anti ezrin (red) antibodies and visualized by wide-field 3D sectioning microscope with Z
step every 0.2 mm. Two different focal planes are shown. Scale bar: 10 mm.
doi:10.1371/journal.pone.0037490.g003
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37490Figure 4. Ezrin ubiquitylation by WWP1. (A) Lysates from 293T cells transfected with the indicated combinations of wild type flag-WWP1, flag-
WWP1 C890A (C/A) and Myc-ubiquitin were immunoprecipitated with an anti-ezrin antibody followed by a blot with a Myc antibody. (B) 293T cells
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bands could be detected.
We also found that the PPVY
477 motif of ezrin was required for
this ubiquitylation. When compared to wild-type ezrin, this
pattern of multi-ubiquitylation was not present in cells expressing
ezrin Y477F, P474A or P475A (Fig. 4E). In ezrin Y477F and
P474A mutants, but not in ezrin P475A mutant, one band was
present, corresponding to a shift of 8 Kd, the size of one ubiquitin
molecule. Since this band was also present in the extract of cells
expressing the catalytically inactive form of WWP1 it suggests that
the monoubiquitylation is not dependent on the activity of WWP1.
All together, these results indicate that ezrin multi-ubiquitylation
by WWP1 requires the interaction between these two proteins via
the PPVY
477motif in ezrin.
As WWP1-dependent ubiquitylation has been shown to affect
the stability of several of its substrates, we determined the possible
role of WWP1 in the degradation of ezrin. Overexpression of
WWP1 in 293T cells failed to cause any changes in ezrin
expression levels (Fig. 4F). Consistent with this conclusion is the
observation that the addition of the proteasomal inhibitor MG132
had no effects on the total amount of ezrin present in the cells
(Fig. 4F), nor on its level of ubiquitylation (Fig. 4G). To further
confirm that WWP1 does not regulate the stability of ezrin,
WWP1 was stably expressed in Flp-InTM T-RExTM 293 cells.
Pulse chase experiments were performed with cells transfected
either with the vector alone or with the vector expressing WWP1.
We found that the rates of endogenous ezrin degradation were
similar between the WWP1 expressing cell line and cells
transfected with the vector alone. We found the ezrin half life to
be 4.5+/21.3 days for vector and 4.07+/20.1 for WWP1
expressing cells (Fig. 4H). Therefore, ubiquitylation of ezrin by
WWP1 is involved in functions other than the stabilization of the
protein.
WWP1 Overexpression Upregulates Met
WWP1 is involved in the positive or negative regulation of
several receptor targets [17–19,27]. We previously showed that
ezrin plays a role in HGF-induced cell morphogenesis, motility [4]
and scattering [9]. Therefore we decided to investigate whether
the interaction between ezrin and WWP1 might play a role in
regulating the stability and/or the activity of Met. We examined
Met protein levels in LLC-PK1 cells stably expressing GFP-
WWP1. We found that after 5 h starvation and in the absence of
HGF stimulation, the level of Met was upregulated in cells
expressing WWP1 when compared to cells overexpressing the
GFP alone (Fig. 5A). To determine whether this effect was
dependent on ezrin, we knocked-down ezrin by transiently
transfecting LLC-PK1 cells, overexpressing WWP1, with a
plasmid encoding short hairpin RNA targeting ezrin (shEz).
Expression of the shRNA led to an efficient knock down of ezrin
(Figure 5B). In cells expressing GFP-WWP1 and the shRNA for
ezrin we observed a decrease in Met levels compared to cells
transfected with GFP alone. Altogether, these results indicated that
WWP1 and ezrin cooperate in the control of Met levels.
To determine if the expression of WWP1 had an effect on
the activity of the receptor, we measured the cell response to
HGF during wound healing. We measured the speed of LLC-
PK1 cells stably expressing either GFP-WWP1 or GFP in
presence or in absence of HGF during wound healing. Upon
HGF treatment the speed of the cells was increased when
compared to that of unstimulated cells. This increase was higher
in cells expressing GFP-WWP1 when compared to cells
expressing GFP alone (Figure 5C left). To determine if this
increased response of Met in the presence of WWP1 was
dependent on ezrin we performed the wound healing on cells
treated either with scramble siRNA as control or siRNA
targeting ezrin. Cells depleted for ezrin showed reduced
response to HGF stimulation when compared to cells transfect-
ed with scramble siRNA (Figure 5C, middle panel). We next
seeked to determine if the increase in HGF response we
observed required ubiquitylated ezrin. We transfected cells
expressing GFP-WWP1 and depleted for ezrin either with
empty vector, wild type ezrin or with ezrin P475A that cannot
be multi- ubiquitylated and we monitored the speed of the cells
in the wound healing assay. Whereas the overexpression of wild
type ezrin restored HGF response to level comparable to that of
cells transfected with non targeting sequences (Scr), cells
expressing ezrin P475A show speed levels similar to that of
controls i.e. silenced cells transfected with an empty plasmid
(vector). Altogether these data indicate that the ubiquitylation of
ezrin by WWP1 is required for WWP1-dependent increase in
Met activity.
Discussion
We and others have previously shown that ezrin participates in
several HGF-induced cellular responses downstream of Met
signalling. Here we show that ezrin, through its ubiquitylation
by WWP1, also act upstream by controlling the level of the
receptor.
WWP1 binds to two domains of ezrin: the FERM domain
and the PPVY
477 motif present in its C-ter domain. The
interaction between the PPVY
477 motif in ezrin and the WW
domains of WWP1 is a key step since mutation of any amino
acids in this motif abolishes ezrin ubiquitylation although an
interaction is still observed between the two proteins. For these
reasons it is not possible to establish a firm conclusion on
whether Y477 phosphorylation is an absolute requirement for
expressing Flag-WWP1, ezrin-VSVG and Myc-His-ubiquitin were lysed either in RIPA buffer or RIPA buffer containing 1% SDS and the ubiquitylated
proteins were purified on TALON beads. The immunoblot was performed with an anti-VSVG antibody. (C) In vitro ubiquitylation was performed in
presence of the indicated proteins. Left panel shows a Ponceau staining. Right panel: the blot was performed with an anti-Myc antibody to detect
ubiquitylated protein. The brackets indicate the extent ubiquitylation of ezrin D29 and WWP1 (D) Ezrin is multi-ubiquitylated. 293T cells were
transfected with the indicated plasmids. Upper panels: Immunoprecipitation of ezrin-Myc was followed by immunoblotswith the anti-VSVG
(ubiquitin) and anti-ezrin antibodies. The asterisk indicates the position of non ubiquitylated ezrin. Lower panels: the immunoblots were performed
on cell lysates with anti-Flag (WWP1) and anti-ezrin antibodies. (E) Ezrin ubiquitylation requires the PPXY motif. Lysates from 293T cells transfected
with the indicated combinations of wild type flag-WWP1, flag-WWP1 C890A, wild type ezrin-VSVG, P474A, P475A, Y477F ezrin-VSVG and Myc-
ubiquitin were immunoprecipitated with an anti-ezrin antibody followed by immunoblot with anti-Myc and -VSVG antibodies. (F) Ezrin steady state
levels are not affected by WWP1 expression. 293T cells were transfected with the indicated combinations of plasmids and treated or not with the
proteasomal inhibitor MG132. Immunoblots were performed with the indicated antibodies. Tubulin serves as a loading control. (G) Ezrin
ubiquitylation with MG132 treatment. 293T cells were transfected with the indicated plasmids and treated or not with MG132. Immunoprecipitation
with anti-VSVG antibody was followed by immunoblotting with anti-Myc and -VSVG antibodies. (H) Expression of WWP1 does not affect the half-life
of ezrin. Stable Flp-In
TM T-REx
TM 293 cell lines expressing wild type PC- tagged WWP1 or vector alone were pulse-labeled for 15 min with
35Smethionine/cysteine and chased for 0, 2, 24, 48, and 72 hours. Autoradiography of ezrin immunoprecipitates is shown.
doi:10.1371/journal.pone.0037490.g004
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isolated in a phospho-dependent screen. Our results suggest that
the interaction of the PPVY
477 motif with the WW domains
may also play a role in the activation of WWP1. Indeed, several
HECT domain-containing E3 ligases are self-inhibited and can
be activated by different means including the binding of their
WW domains to the PPXY motif of their binding partners [28–
30].
We have previously described an interaction between the Fes
kinase SH2 domain and ezrin that occurs through phosphorylated
tyrosine 477 of ezrin [9]. Interestingly, ezrin/Fes interaction at
cell–cell contacts plays an essential role in HGF-induced cell
scattering Therefore two different proteins which regulate Met
receptor activity bind to this linker region through their SH2 and
WW domains respectively. This raises the question of whether the
binding of these two proteins is exclusive or whether it can occur
simultaneously with different pools of ezrin consistent with a role
for ezrin in organizing signalling complexes.
We report here, for the first time that ezrin is ubiquitylated by
WWP1. We did not observe changes in the half-life of ezrin when
the cells express WWP1 suggesting that ezrin ubiquitylation by
WWP1 serves functions other than degradation of ezrin. We show
here that the interaction of ezrin with WWP1 upregulates the Met
receptor in the absence of HGF stimulation. Various mechanisms
have been shown to regulate Met stability and degradation. One
mechanism involves c-Cbl ubiquitin ligase. The c-Cbl-mediated
ubiquitylation of Met following HGF stimulation triggers Met
internalization and down regulation. Uncoupling Met from c-Cbl-
mediated ubiquitylation increases the stability of the receptor that
acquires transforming activity in fibroblast and epithelial cells [31–
33]. Moreover, it has been reported that the transmembrane
leucine-rich repeat protein LRIG1 interacts with and destabilizes
Met in the absence of HGF and in a Cbl-independent manner
through a mechanism that is not as yet defined [34]. The effect of
WWP1 expression on Met stability that we describe here has
previously been observed for EGFR and ErbB2. It has been shown
Figure 5. Ezrin ubiquitylation by WWP1 is required for Met upregulation. (A) Met levels in LLC-PK1 cells expressing GFP-WWP1 or GFP
alone. Left panel: Blots were performed with anti-Met and anti-tubulin antibodies. Right panel: The quantification of Met level normalized to tubulin
results from five independent experiments. Data are expressed as mean 6 SEM, *P,0.05 (paired t-test). (B) Ezrin depletion prevents Met
upregulation. Stable GFP-WWP1 cells were transfected with plasmids coding for shRNA targeting ezrin (shEz) or a scramble sequence (Scr). Left panel:
Cell lysates were blotted with the indicated antibodies. Right panel: the quantification of Met level normalized to tubulin results from five
independent experiments. Data are expressed as mean 6 SEM, *P,0.05 (paired t-test). (C) Cell speed measured in a wound healing assay. In each
graph, the bars represent the increase in the speed of cells treated with HGF as compared to the speed of untreated cells. Left panel: LLC-PK1 cells
expressing either GFP or GFP-WWP1. Middle panel: LLC-PK1 cells expressing GFP-WWP1 and transfected with plasmids coding for scramble shRNA
(Scr) or shRNA targeting ezrin. Right panel: LLC-PK1 cells expressing GFP-WWP1 and shRNA targeting ezrin were transfected with either an empty
vector (vector) or plasmids coding for ezrin wild type or ezrin P475A. The data correspond to three independent experiments. Significance was tested
using a two-way ANOVA model with interaction (SigmaStat). The pairwise comparisons were performed with the Student-Newman-Keuls method
using an a risk of 0.05.
doi:10.1371/journal.pone.0037490.g005
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of the RING finger protein 11 (RNF11) E3 ubiquitin ligase that
targets EGFR and ErbB2 for degradation [19]. We propose that a
similar mechanism may operate for Met regulation. WWP1 may
regulate Met stability and consequently its activity indirectly by
targeting positive or negative regulators of the receptor. In this
context, ubiquitylated ezrin may function as an adaptor recruiting
the specific substrates for WWP1.
Our results demonstrate that in a wound healing assay,
expression of WWP1 leads to higher migratory rates in response
to HGF stimulation. A likely explanation is that the upregulation
of Met observed in cells expressing GFP-WWP1 better sustains
signalling upon HGF stimulation. Both the upregulation of the
receptor and its increased signalling function observed in the
process of cell migration also require ubiquitylated ezrin. We
propose that, through its ubiquitylation, ezrin may facilitate the
assembly of a complex comprising WWP1 to consequently
stabilize the receptor.
Genetic and functional analyses in human cancers have shown
that WWP1 is a potential oncogene. Genomic amplification of
WWP1 has been detected in approximately 40% of breast and
prostate human cancers [35,36]. Knockdown of WWP1 in breast
cancer epithelial cell lines induces growth arrest and apoptosis
further supporting a role in tumorigenesis [36]. Recent findings
indicate that ezrin is required for metastasis of breast carcinoma,
osteosarcoma and HGF-induced rhabdomyosarcoma [37–39].
Our results link WWP1 and ezrin to the Met receptor activity,
providing a molecular basis to the role of ezrin and WWP1 in
tumor progression. It would be thus important to address the role
of ezrin/WWP1 interaction in the regulation of Met activity in
tumor cells and in metastasis as Met plays a central role in these
processes [1].
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